These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17456201)

  • 1. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation.
    Campbell PM; Salam A; Ryan EA; Senior P; Paty BW; Bigam D; McCready T; Halpin A; Imes S; Al Saif F; Lakey JR; Shapiro AM
    Am J Transplant; 2007 May; 7(5):1242-8. PubMed ID: 17456201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.
    Roelen DL; Huurman VA; Hilbrands R; Gillard P; Duinkerken G; van der Meer-Prins PW; Versteeg-van der Voort Maarschalk MF; Mathieu C; Keymeulen B; Pipeleers DG; Roep BO; Claas FH
    Clin Exp Immunol; 2009 Apr; 156(1):141-8. PubMed ID: 19161445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperacute Rejection in a Kidney Transplant With Negative Crossmatch: A Case Report.
    Pereira M; Guerra J; Gonçalves J; Santana A; Nascimento C; da Costa AG
    Transplant Proc; 2016 Sep; 48(7):2384-2386. PubMed ID: 27742303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts.
    Hilbrands R; Gillard P; Van der Torren CR; Ling Z; Verheyden S; Jacobs-Tulleneers-Thevissen D; Roep BO; Claas FH; Demanet C; Gorus FK; Pipeleers D; Keymeulen B
    Transplantation; 2013 Jul; 96(2):162-9. PubMed ID: 23857001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.
    Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB
    Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
    İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
    Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.
    Karpinski M; Rush D; Jeffery J; Exner M; Regele H; Dancea S; Pochinco D; Birk P; Nickerson P
    J Am Soc Nephrol; 2001 Dec; 12(12):2807-2814. PubMed ID: 11729251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients.
    Staeck A; Khadzhynov D; Kleinsteuber A; Lehner L; Duerr M; Budde K; Lachmann N; Halleck F; Staeck O
    Transpl Immunol; 2020 Dec; 63():101333. PubMed ID: 32919027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation.
    Müller-Steinhardt M; Fricke L; Kirchner H; Hoyer J; Klüter H
    Clin Transplant; 2000 Feb; 14(1):85-9. PubMed ID: 10693642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insights into pretransplant allosensitization in heart transplant recipients in the contemporary era of immunosuppression and rejection surveillance.
    Svobodova E; Gazdic T; Kubanek M; Vymetalova J; Voska L; Kment M; Lanska V; Kolesar L; Urban M; Netuka I; Pirk J; Melenovsky V; Kautzner J; Slavcev A; Malek I
    Transpl Int; 2016 Jan; 29(1):63-72. PubMed ID: 26340387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of anti-human leukocyte antigen class 1 antibodies following allogeneic islet cell transplantation.
    Lobo PI; Spencer C; Simmons WD; Hagspiel KD; Angle JF; Deng S; Markmann J; Naji A; Kirk SE; Pruett T; Brayman KL
    Transplant Proc; 2005 Oct; 37(8):3438-40. PubMed ID: 16298621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of pretransplant donor-specific antibodies on graft outcome in renal transplantation: a six-year follow-up study.
    David-Neto E; Souza PS; Panajotopoulos N; Rodrigues H; Ventura CG; David DS; Lemos FB; Agena F; Nahas WC; Kalil JE; Castro MC
    Clinics (Sao Paulo); 2012; 67(4):355-61. PubMed ID: 22522761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
    Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
    Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation.
    Lobashevsky AL; Senkbeil RW; Shoaf J; Mink C; Rowe C; Lobashevsky ES; Burke R; Hudson S; Deierhoi MH; Thomas JM
    Clin Transplant; 2000 Dec; 14(6):533-42. PubMed ID: 11127305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class I sensitization in islet transplant recipients: report from the Collaborative Islet Transplant Registry.
    Naziruddin B; Wease S; Stablein D; Barton FB; Berney T; Rickels MR; Alejandro R
    Cell Transplant; 2012; 21(5):901-8. PubMed ID: 22080832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.